Shruutas Pharmaceutical Private Limited
About Shruutas Pharmaceutical Private Limited
Data last updated:
Shruutas Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 April 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2022PTC381575.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rahul Mininath Jadhav and Suresh Laxman Shinde.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹37.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹97,556 (net margin 2.6%) and EBITDA of ₹3.22 Lakh (EBITDA margin 8.7%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shruutas Pharmaceutical Private Limited's registered office is in Thane, Maharashtra.
- Registered Address2nd Floor Pap R – 600, Ttmc Industrial Area Rabale MIDC Rabale, Thane, Maharashtra, India – 400710
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shruutas Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shruutas Pharmaceutical Private Limited, buy the company report.
Financials of Shruutas Pharmaceutical Private Limited
FY 2025 filings availableShruutas Pharmaceutical Private Limited reported revenue of ₹37.07 Lakh (up 556% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 556% in the latest year. EBITDA rose 129% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹3.22 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹97,556 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 8.7% | |
| Net Profit Margin | 2.6% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Shruutas Pharmaceutical Private Limited, buy the company report.
Board of directors of Shruutas Pharmaceutical Private Limited
Shruutas Pharmaceutical has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Mininath Jadhav | Director | 27 Feb 2024 | 2 Years 8 Months | Current |
| Suresh Laxman Shinde | Director | 17 Jul 2023 | 3 Years 3 Months | Current |
| Kiran Laxman Shinde | Director | 27 Apr 2022 | 4 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Shruutas Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shruutas Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Shruutas Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Shruutas Pharmaceutical Private Limited has 5 board changes on record since 2022: 3 appointments and 2 cessations. The latest: Rahul Mininath Jadhav ceased to be Director on 30 Jan 2025.
Frequently asked questions
Shruutas Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 April 2022 (4+ years old) and is registered under CIN U24100MH2022PTC381575.
Shruutas Pharmaceutical has 3 current directors:
- Rahul Mininath Jadhav - Director
- Suresh Laxman Shinde - Director
- Kiran Laxman Shinde - Director
The latest financial statements of Shruutas Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Shruutas Pharmaceutical is U24100MH2022PTC381575. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shruutas Pharmaceutical was incorporated on 27 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Rahul Mininath Jadhav ceased to be Director on 30 Jan 2025. Rahul Mininath Jadhav was appointed as Director on 27 Feb 2024. Rahul Sanjay Kanse ceased to be Director on 23 Aug 2023. Shruutas Pharmaceutical has 5 board changes on record in total.
The registered office of Shruutas Pharmaceutical is at 2nd Floor Pap R – 600, Ttmc Industrial Area Rabale MIDC Rabale, Thane, Maharashtra, India – 400710.
Shruutas Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Shruutas Pharmaceutical is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.
Shruutas Pharmaceutical can be reached at its registered office: 2nd Floor Pap R – 600, Ttmc Industrial Area Rabale MIDC Rabale, Thane, Maharashtra, India – 400710.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
